Biocon Rings In 2020 With Gusto, PE Investment In Biologics Arm
New Biosphere Subsidiary Set Up
Private equity group True North continues to back the Biocon group and is picking up a minority stake in Biocon Biologics in a deal that values the subsidiary at $3bn. Separately, another subsidiary, Biocon Biosphere, has also been set up as part of efforts to unlock the full potential of the business.
